Filana Therapeutics, Inc. Class of Warrant or Right, Outstanding
Filana Therapeutics, Inc. (FLNA) had Class of Warrant or Right, Outstanding of 0 shares as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-03-12
- 2025-12-31: Class of Warrant or Right, Outstanding 0.00 shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 0.00 shares.
- 2025-06-30: Class of Warrant or Right, Outstanding 0.00 shares.
- 2025-03-31: Class of Warrant or Right, Outstanding 0.00 shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2025-12-31 | 0.00 shares 10-K · filed 2026-03-12 | |
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 0.00 shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-08 | |
| 2024-12-31 | 0.00 shares 10-K · filed 2026-03-12 | |
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-07 | |
| 2024-01-02 | 16.89M shares 10-K · filed 2026-03-12 | 16.89K shares 10-Q · filed 2024-08-08 |
| 2020-12-31 | 554.02K shares 10-K · filed 2021-03-23 | |
| 2019-12-31 | 4.50M shares 10-K · filed 2021-03-23 | |
| 2018-12-31 | 9.13M shares 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |